Viewing Study NCT03979495


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-02-22 @ 6:44 PM
Study NCT ID: NCT03979495
Status: COMPLETED
Last Update Posted: 2024-05-10
First Post: 2019-05-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: mFOCUS (Multilevel FOllow-up of Cancer Screening)
Sponsor: Massachusetts General Hospital
Organization:

Study Overview

Official Title: mFOCUS (Multilevel FOllow-up of Cancer Screening)
Status: COMPLETED
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: mFOCUS
Brief Summary: To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.
Detailed Description: Standard care consists of well-characterized existing decision support and systems for follow-up in these three participating primary care networks and their affiliated integrated delivery systems (Brigham and Women's Hospital, Massachusetts General Hospital, and Dartmouth Hitchcock Health, the largest health care provider in New Hampshire). The primary outcome will be whether an individual receives follow-up, defined based on the type of screening abnormality and organ type (breast, cervical, lung or colorectal cancer), within 120 days of becoming eligible for mFOCUS. Secondary comparisons will assess multi- and cross-level (individual, team, system) outcomes. The study design will allow us to examine the marginal effectiveness of system, team and individual-level enhancements, and exploratory analyses will address subgroups defined by race/ ethnicity, socioeconomic status and cancer type.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: